Suppr超能文献

XVIII 型胶原(COL-18N)的血管内皮特异性异构体:血友病性关节病血管完整性的标志物。

Endothelial specific isoform of type XVIII collagen (COL-18N): A marker of vascular integrity in haemophilic arthropathy.

机构信息

Pediatric Haematology/Oncology, Childrens Hospital, Ain Shams University, Cairo, Egypt.

Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

出版信息

Haemophilia. 2022 Sep;28(5):849-856. doi: 10.1111/hae.14593. Epub 2022 May 30.

Abstract

BACKGROUND

Haemophilic arthropathy (HA) is a major complication in haemophilia. Collagens IV, XV and XVIII are responsible for maintaining the integrity of the vessel wall in the joint. Following joint remodelling and damage, the short isoform of collagen type XVIII (COL-18N) is degraded, releasing measurable fragments. Our goal was to quantify the specific isoform COL-18N in haemophilia A patients and to assess its relation to the clinical and radiological data as well as haemophilia joint health score (HJHS), functional independence score for haemophilia (FISH), and haemophilia quality of life (Haemo-Qol).

METHODS

This cross-sectional study included 50 haemophilia A patients recruited from the Paediatric Haematology and Oncology unit, Ain Shams University, Cairo, Egypt. Quantification of COL-18N was done by ELISA. Assessment of joint state clinically using FISH and HJH scores and radiologically by X-rays and ultrasound.

RESULTS

Haemophilia A patients had significantly higher median COL-18N levels compared to the control group. Inhibitor positive and negative haemophilia A patients as well as those on non-steroidal anti-inflammatory drug and those not had comparable COL-18N levels. Patients with ≥2 target joints had significantly higher COL-18N level compared to those with one or those without target joints. There were significant positive correlations between COL-18N level and the total HJHS, Haemo-Qol, the HEAD-US score and annual bleeding rate.

CONCLUSION

Our results demonstrated a high level of COL-18N in haemophilia A patients and argued its benefit as a potential marker for monitoring the development of haemophilic arthropathy and tailoring the optimal treatment to prevent further joint damage.

摘要

背景

血友病性关节病(HA)是血友病的主要并发症。IV、XV 和 XVIII 型胶原负责维持关节中血管壁的完整性。在关节重塑和损伤后,短型 XVIII 型胶原(COL-18N)被降解,释放可测量的片段。我们的目标是定量检测血友病 A 患者的特定型 COL-18N,并评估其与临床和放射学数据以及血友病关节健康评分(HJHS)、血友病功能独立性评分(FISH)和血友病生活质量(Haemo-Qol)的关系。

方法

本横断面研究纳入了来自埃及开罗艾因夏姆斯大学儿科血液学和肿瘤学单位的 50 名血友病 A 患者。通过 ELISA 定量检测 COL-18N。使用 FISH 和 HJH 评分进行关节临床评估,使用 X 射线和超声进行关节放射学评估。

结果

血友病 A 患者的 COL-18N 中位数水平明显高于对照组。抑制剂阳性和阴性的血友病 A 患者以及使用非甾体抗炎药和未使用非甾体抗炎药的患者的 COL-18N 水平无差异。有≥2 个靶关节的患者的 COL-18N 水平明显高于有 1 个或没有靶关节的患者。COL-18N 水平与 HJHS 总分、Haemo-Qol、HEAD-US 评分和年出血率呈显著正相关。

结论

我们的研究结果表明,血友病 A 患者的 COL-18N 水平较高,这表明它可能作为监测血友病性关节病发展和调整最佳治疗以预防进一步关节损伤的潜在标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验